Terry Anderson

Terry Anderson, PhD, is currently a Senior Medical Director specializing in Rare Disease at Pfizer Pharmaceuticals, where they leverage extensive experience in Neuroscience and Specialty Products. Their background includes significant roles in clinical trials from Phase I to IV, as well as leading pivotal registration trials. Previously, Terry served as the Urgent Care Chief at Group Health Cooperative and held the position of Medical Science Liaison at Wyeth Pharmaceuticals. With a strong ability to cultivate relationships with key opinion leaders, they are adept at supporting advisory boards and training initiatives in both commercial and medical contexts.